Turn the theoretical benefits of the blockchain technology into business value. Read more
Publications Read our latest press articles!
Press Contact
+49 621 86298 800    sgsc@camelot-itlab.com

Press Releases


Camelot distinguished again as “Best Consultancy” in 2018

The quality and agile advice convinced the judges Mannheim, 04/24/2018 For the fifth time in succession, Camelot was honored by the business magazine brand eins and statista, the largest online statistics portal, as the “Best Consultancy” in Germany. This not only testifies to the consistently high quality of Camelot’s consulting. The award also demonstrates that […]

Read more

Camelot Hypertrust X-Chain provides data security for innovative cancer therapies

CAMELOT Consulting Group introduces new patient-centered blockchain application for pharma and healthcare Mannheim, Montreux, 04/09/2018 – Innovative cell therapies are often the last but most promising form of treatment for cancer patients. However, such procedures are highly complex and involve the exchange of sensitive patient data between many stakeholders. With Hypertrust X-Chain, the CAMELOT Consulting […]

Read more

CAMELOT’s growth strategy banks on international talent pools

Bulgarian IT specialist consulting is helping meet the high need for IT talent in Germany Mannheim, Sofia, April 5, 2018 – The CAMELOT Consulting Group is getting reinforcements from the Bulgarian IT consulting company IBsolution Bulgaria. The Bulgarian IT specialists, who will now be on the market under the brand name Camelot ITLab Bulgaria, support […]

Read more

Stay in touch

Follow us on your preferred channel

For questions and inquiries, please feel free to contact us.

This site uses cookies to provide you with a personalized browsing experience. By using this site you agree to our use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.